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Abstract 
Polysaccharide-based biopolymers have many 
material properties relevant to industrial and 
medical uses, including as drug delivery agents, 
wound healing adhesives, and food additives and 
stabilizers. Traditionally, polysaccharides are 
obtained from natural sources. Microbial synthesis 
offers an attractive alternative for sustainable 
production of tailored biopolymers. Here, we 
review synthetic biology strategies for select 
“green” biopolymers: cellulose, alginate, chitin, 
chitosan, and hyaluronan. Microbial production 
pathways, opportunities for pathway yield 
improvements, and advances in microbial 
engineering of biopolymers in various hosts are 
discussed. Taken together, microbial engineering 
has expanded the repertoire of green biological 
chemistry by increasing the diversity of biobased 
materials. 
 
Context for Polysaccharide-based 
Biopolymers  
Polysaccharide-based scaffolds have 
applications in medicine, as agricultural and food 
products, and as biomaterials with bioactive, 
biocompatible, and biodegradable properties (Table 
1). Biopolymers, such as the chitin derivative 
chitosan, have been shown to accelerate wound 
healing (1) and offer opportunities for scalable 
manufacturing in the bioprinting industry (2). 
Traditionally, biopolymers are obtained from 
natural sources by extraction from the environment 
and require further downstream processing 
including, in many cases, the use of harsh chemicals 
to obtain desired material properties. For example, 
chitin, which is traditionally sourced from shellfish, 
is a waste product resulting from the seafood 
industry that requires chemical protection and 
deprotection steps of various hydroxyl groups to 
impart desired functional properties (3).  
Biobased production of chemicals from sugars 
and biomass is more sustainable than traditional 
non-renewable petrochemical routes (4). The cell 
factory approach, where a chemical is synthesized 
in vivo, utilizes simple and inexpensive starting 
materials like glucose. Metabolic pathways can be 
overexpressed and optimized in native organisms or 
reconstructed into heterologous hosts for improved 
yields. In the past 30 years, notable advances have 
been made in the microbial biosynthesis of building 
block chemicals, such as dicarboxylic acids (e.g. 
glucaric acid (5)), diamines (e.g. putrescine (6)), 
hydroxyacids (e.g. 3-hydroxybutyrate (7)), and 
diols (e.g. butanediol (8)). While microbial 
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production of bioplastics from hydroxyacid 
monomers is a keystone example of industrially 
relevant biopolymerization (9), this mini-review 
will not cover this area as other reviews sufficiently 
discuss this topic (10).  
By harnessing nature’s toolbox of diverse 
biochemistry, microbial production of building 
block monomers can be extended to in-cell 
functionalization and polymerization. One-step 
microbial production of biopolymers is a 
sustainable alternative to avoid the use of 
environmentally damaging chemicals and catalysts 
and offers a scalable process that does not depend 
on harvesting from fragile ocean ecosystems, as is 
the case for biopolymers chitin and alginate; 
competing for valuable land as is the case for 
cellulose; or interfering with ethics of animal-based 
products as is the case for hyaluronan. Synthesizing 
biopolymers through enzymatic or whole cell 
biocatalysis allows for higher regio- and 
stereoselectivity for in-cell composition-tailoring 
of polymers, which can reduce downstream 
processing. Useful objectives for metabolic 
engineering are polymer chain length by molecular 
weight control, sequence of saccharide units for 
composition control, and yield improvements for 
increased economic feasibility. While greener 
methods do exist for biopolymer extraction from 
natural sources, such as utilization of ionic liquids 
for extracting chitin from crustacean shells (11), the 
economic competitiveness versus synthetic biology 
strategies has not yet been demonstrated. 
This review highlights strategies for 
cellular biosynthesis of select industrially and 
                                                      
1 Abbreviations used: AcCoA, Acetyl Coenzyme-A; 
BC, bacterial cellulose; BCS, bacterial cellulose 
synthase; CRISPR, clustered regularly interspaced 
short palindromic repeats; DO, dissolved oxygen; 
EPS, exopolysaccharides; F6P, fructose-6-
phosphate; G1P, Glucose-1-phosphate; G6P, 
glucose-6-phosphate; GDP-Man, GDP-mannose; 
GDP-ManA, GDP-mannuronic acid; GFA1, 
glutamine-fructose-6-phosphate transaminase; Glc, 
glucose; GlcN-6-P, glucosamine-6-phosphate; 
GlcN, glucosamine; GlcNAc-1-P, N-
medically relevant polysaccharides: cellulose, 
alginate, chitin, chitosan, and hyaluronan. These 
biopolymers are examples of polysaccharides that 
are synthesized by the synthase-dependent pathway 
where polymerization and translocation processes 
are performed by a single synthase protein complex 
(12). Native biosynthetic mechanisms, such as 
microbial exopolysaccharide (EPS)1 biosynthesis, 
serve as a template for biotechnological production 
of biomaterials. Typically, synthase-dependent 
pathways favor homopolymer formation, and the 
polymers are released into the extracellular 
environment as non-covalently associated EPS 
fibers. These fibers are secreted into the 
surrounding environment at high molecular weights 
and can be harvested from cell cultures in a cost-
effective manner by filtration. Several studies have 
demonstrated the synthesis of natural or novel 
variants of biopolymers from engineered organisms 
(13). General production strategies for microbial 
biosynthesis of biopolymers, such as increasing the 
pool of metabolite precursor supply and carbon flux 
toward the end-product, are discussed within. Due 
to the diversity of material design options, 
microbial production of biopolymers also offers an 
attractive opportunity toward the production of 
new, custom-made materials beyond those from 
natural sources, such as engineered biosynthesis of 
non-natural fluorinated polyhydroxyalkanoates for 
bioplastics (15). 
acetylglucosamine-1-phosphate; GlcNAc-6-P, N-
acetylglucosamine-6-phosphate; GlcNAc, N-
acetylglucosamine; HA, hyaluronic acid; HAD, 
haloacid dehalogenase-like; HAS, hyaluronan 
synthase; M1P, mannose-1-phosphate; M6P, 
mannose-6-phosphate; Man, mannose; ManA, 
mannuronic acid; OAA, oxaloacetate; TCA, 
tricarboxylic acid; UDP-Glc, UDP-glucose; UDP-
GlcNAc, UDP-N-acetylglucosamine; UDP-GlcUA, 
UDP-glucuronic acid; UDP-GulA, UDP-guluronic 
acid 
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Synthetic biology strategies for 
polysaccharide biosynthesis 
Cellulose 
Cellulose is the most abundant polymer on the 
planet and is one of the most widely used natural 
materials in products such as papers and textiles. 
The value of the global market size for cellulose 
fiber was USD 20.61 billion in 2015 and is 
projected to reach USD 48.37 billion by 2025  (16). 
Cellulose is a monomeric polymer of β(1→4) D-
glucose units (Fig. 1a) forming chains that twist 
into higher crystalline structures of cellulose I 
(triclinic structures Iα and Iβ ) and cellulose II. 
Cellulose crystals are formed by aggregation of 
nearby chains secreted from collections of cellulose 
synthase complexes arranged in the cell membrane, 
typically forming rosettes in plant cells and axially 
aligned lines in bacteria (17).   
Bacterial cellulose (BC) production offers 
unique advantages over plant fiber processing by 
reducing the chemical and power input during 
purification and offering access to the cell surface 
through the media to modulate crystal formation 
during synthesis. Manual addition of hydrogen 
bonding molecules to the culture media can control 
Iα/Iβ ratios and molecular weights in resulting 
cellulose particles (18, 19). BC crystals interweave 
in random patterns according to bacterial 
movement and form a pellicle at the oxygen-media 
interface that grows to take the shape of the 
bioreactor. Pellicles (also called tea mushroom or 
Symbiotic Culture of Bacteria and Yeast (SCOBY) 
occur naturally on the surface of Kombucha 
fermented tea cultures and have been used as 
materials for thousands of years (20). When grown 
in controlled conditions, regular cellulose films 
with complex structure can incorporate functional 
additives to achieve optical activity, conductivity, 
magnetism, and photo-catalytic degradation (21). 
The genetic tractability of bacteria makes cellulose 
materials synthesis an attractive target for synthetic 
biology.  
 Bacterial cellulose synthase (BCS) requires c-
di-GMP for activation and is internally regulated by 
accumulation of UDP, which is released from UDP-
glucose during polymerization (Fig. 2) (22). 
Heterologous expression of Gluconacetobacter 
xylinus cellulose synthase genes from plasmids in 
Escherichia coli led to amorphous synthesis and a 
non-native cellulose II structure indicating the 
importance of membrane organization to 
crystallization (23). Bacteria that produce 
crystalline fibrils include a fourth gene bcsD that is 
likely to facilitate the formation of multi-enzyme 
structures in the membrane, evidenced by 
knockouts that produce cellulose with reduced 
crystallinity (24). BCS operons are known to 
occasionally include a gene encoding 
endoglucanase, BcsZ, which is capable of 
specifically degrading amorphous improperly 
formed cellulose chains. Inclusion of BcsZ protein 
after fibrils are formed increases crystallinity in 
reconstituted in vitro systems (24). Induction by 
quorum sensing molecule N-acyl homoserine 
lactone can be used to penetrate the pellicle layer 
and lead to effective control of engineered 
expression in a newly isolated strain of 
Komagataeibacter rhaeticus (25). Maximum titers 
of 15.3 g/L at production rates of up to 3.1 g/L/h 
have been achieved in bioreactor fermentations 
with Acetobacter (Table 1) (26). 
Alginate 
Alginates are natural biopolymers that are 
abundant in marine brown algae (Phaeophyceae) 
(27) and in Pseudomonas and Azotobacter genera 
of bacteria (28). These EPS are the major structural 
component of algal cell walls, comprising up to 40-
45% of the total algal dry matter (29), whereas in 
Pseudomonas and Azotobacter, alginates contribute 
to highly-structured biofilm-matrix and cyst-wall 
formations, respectively (30). Commercially, 
alginates have widespread use as stabilizers, 
viscosifiers, and gelling agents in food, cosmetics, 
beverage, paper, printing, and pharmaceutical 
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industries (28).  Globally, the demand for alginates 
was valued at USD 624 million in 2016, and the 
demand is projected to reach USD 923.8 million by 
2025 with a consumption volume of 21,516 tons 
(31).  
Structurally, alginates are a family of linear, 
non-repeating block copolymers consisting of 
variable ratios of β-D-mannuronic acid (M) and its 
C5 epimer α-L-guluronic acid (G) linked by β-
(1,4)-glycosidic bonds (Fig. 1b) (32). Variation in 
the molar ratios of M to G residues controls the 
molecular weight and material properties of 
alginates. Because of their unique water retaining 
capability, biocompatibility, low toxicity, relatively 
low cost of production, and temperature-
independent mild gelation/sol-gel transition ability 
in the presence of multivalent cations (e.g., Ca2+), 
alginates are excellent biomaterials for use in 
biomedical applications, including wound healing, 
dental implants, drug delivery systems, tissue 
engineering, and regenerative medicine (33). 
The alginate biosynthesis pathway has been 
extensively investigated in P. aeruginosa (34) and 
A. vinelandii (35), but the complex polymerization, 
transport, and secretion system, as well as 
regulatory mechanisms controlling the pathway, 
are not fully understood. Metabolic engineering 
efforts for increasing alginate production are still in 
their infancy. Alginate production is tightly 
regulated in bacteria thus efforts have been made to 
characterize and engineer the regulatory system in 
Pseudomonas fluorescens (36) to identify the 
correlation between precursor availability and 
alginate production. Maleki and colleagues (37) 
showed increased alginate production (2.2 g/L) 
from glycerol in an engineered P. fluorescens 
strain, in which deletion of glucose-6-phosphate 
dehydrogenase redirected more carbon flux through 
the Entner-Doudoroff pathway to produce alginate 
precursor fructose-6-phosphate (F6P) (Fig. 2). A 
similar correlation between alginate production and 
precursor availability was observed in another 
recent study with P. fluorescens (38). Studies with 
A. vinelandii (39) utilized a different strategy, in 
which increased carbon fluxes were channeled 
towards alginate production by disrupting the 
competing polyhydroxybutyrate pathway. 
Implementing this strategy resulted in an alginate 
titer of up to 6.6 g/L with a yield of 1.9 g/g sucrose. 
Single gene-deletion studies in A. vinelandii (39, 
40) also increased alginate yield (0.66 g/g on 
sucrose) (Table 1), and lowered the degree of 
acetylation for altered molecular composition. 
More recently, alginate overproduction was 
reported during biofilm formation in a newly 
discovered strain Pseudomonas mandelii 6A1 (41) 
that was isolated from Antarctica (41). Biofilm 
formation by the strain was increased at lower 
temperatures due to increased alginate productivity, 
which in turn was correlated to the downregulation 
of the regulatory protein MucA, which acts as a 
repressor in the alginate operon (41). 
Synthetic biology strategies for 
aminopolysaccharide biosynthesis 
Chitin and chitosan 
The aminopolysaccharide monomer 
glucosamine (GlcN) and its derivative N-
acetylglucosamine (GlcNAc) are attractive 
candidates for microbial biosynthesis because of 
the facility of the amine group for functionalization 
and the utility for subsequent polymerization into 
chitin and chitosan (Fig. 2). GlcN and GlcNAc are 
glucose moieties with C2 hydroxyl substitution by 
an amino group and acetylated amino group, 
respectively. Aminopolysaccharides and 
subsequent biopolymers have traditionally been 
obtained through strong acid hydrolysis of chitin 
from shellfish. In recent years, microbial 
production of GlcN and derivatives has been 
demonstrated in a variety of hosts including E. coli, 
Bacillus. subtilis, and Saccharomyces cerevisiae 
(42). 
In E. coli, expression of GlcNAc transferase 
and deletion of nagE, a GlcNAc transporter, 
increased GlcN titer to 17 g/L (43). The GlcNAc 
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synthesis module has been strengthened at the 
transcriptional level by increasing enzyme 
expression through testing a range of promoters for 
two key enzymes, glucosamine synthase and 
glucosamine acetyltransferase (44). Elimination of 
acidic byproducts was accomplished by knocking 
out ldh and pta of the lactate and acetate synthetic 
pathways, respectively. By overexpressing 
glucosamine synthase (GlmS), inactivating 
catabolic genes, and utilizing a 2-stage fed batch 
fermentation, Deng et al. (43) achieved GlcN titers 
of up to 110 g/L in E. coli in a fed-batch 
fermentation (Table 1). 
In B. subtilis, expressing various combinations 
of synthetic small regulatory RNAs and Hfq protein 
targeting pfk (encoding phosphofructokinase) in 
glycolysis and glmM (encoding 
phosphoglucosamine mutase) in peptidoglycan 
synthesis improved GlcNAc titers to 31.65 g/L in a 
3-L fed batch bioreactor (45). With a dynamic 
metabolomics approach, Liu et al. found that a 
futile cycle between N-acetylglucosamine-6-
phosphate (GlcNAc-6-P) and GlcNAc is the 
primary challenge for pathway productivity, due to 
high energy demands of ATP phosphorylation-
dephosphorylation (46). Deletion of the responsible 
glucokinase doubles GlcNAc productivity through 
a dual effect of increasing ATP and restoring 
healthy growth to the cell.  
In S. cerevisiae, a synthetic suicide riboswitch 
that regulated growth in response to the precursor 
GlcN-6-P was applied to screen for overproducers 
of GlcNAc. The growth-coupled circuit allowed for 
screening of an effective glutamine-fructose-6-
phosphate transaminase (GFA1) mutant and 
haloacid dehalogenase-like (HAD) phosphatase 
(47). The mutant contained changes in GFA1 
expression, which is the first and rate-limiting step 
of chitin biosynthesis, along with overexpression of 
HAD phosphatase YqaB, specific for conversion of 
GlcNAc-6-P to GlcNAc. Subsequently, GlcNAc 
production was further improved by reducing 
glycolytic flux by the disruption of pfk-2, achieving 
titers of 1.2 g/L when fed glucose and 1.8 g/L when 
fed galactose, in shake flask fermentation (48). 
Under galactose feeding, deletion of pfk-2 allowed 
for enough reduction of glycolysis to activate 
gluconeogenesis thus allowing for galactose to be 
used as a sole carbon source.  
Microbial production challenges in the 
biosynthesis of GlcN and GlcNAc include feedback 
inhibition affects where GlcN-6-P is a strong 
inhibitor of GlcN synthase and GlcN degradation, 
thus limiting the accumulation of GlcN inside the 
cell (Fig. 2) (49). Additionally, aminosugars can 
serve as alternative carbon and nitrogen sources, so 
it’s difficult to achieve high-titers in culture broth, 
unless a recovery strategy is incorporated in the 
fermentation (43). UDP-N-acetylglucosamine 
(UDP-GlcNAc) is normally maintained at high 
intracellular concentrations in growing bacterial 
cells to balance growth and production as the sugar 
donor for the synthesis of N-acetylated 
chitooligosaccharide, the precursor for the 
biosynthesis of peptidoglycan. Amino sugars 
containing free amino groups are unstable in 
aqueous solution at neutral pH where GlcN can 
undergo spontaneous rearrangement and 
dimerization to form fructosazine, D-arabinose, and 
pyrazine derivatives, among others (50). Thus, 
biopolymerization is advantageous to circumvent 
degradation issues. Opportunities exist for 
combining strategies for GlcN and GlcNAc 
overproduction for subsequent biopolymerization. 
Chitin is the second most abundant biopolymer 
on the planet and is found in almost all fungi, many 
animals (invertebrates), several protists, and a few 
algae, playing an essential role in structure. Over 
800 putative chitin synthases associated with 130 
genomes have been identified (51). Chitin is a 
hexosamine biopolymer composed of as many as 
5,000 β-(1,4)-glycosidically linked GlcNAc units 
cross-linked by hydrogen bonding (Fig. 1c). 
Chitosans are deacetylated chitin, as 
heteropolymers of GlcNAc and GlcN units (Fig. 
1d). Chitosans are variable mixtures of molecules 
depending on degree of polymerization and degree 
of acetylation and are valuable functional 
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biopolymers due to their physicochemical and 
biological compatibility. Chitosans have many 
agricultural, industrial, and biomedical applications 
including use as an agricultural agent for plant 
defense and yield increase (52), drug delivery (53), 
wound healing (54), water filtration (55), and bio-
printing (2). Chitosan trisaccharide is a valuable 
precursor for synthesis of epitopes such as type II 
blood group antigens (56). The global market size 
for chitin and chitosan was valued at USD 3.19 
billion in 2015 and is projected to reach USD 17.84 
billion by 2025 (57, 58).  Microbial production of 
chitin and chitosan offers a green alternative to 
shellfish harvesting and allows for control of degree 
of polymerization and acetylation (59).  The 
Montagu group pioneered a cell factory approach 
for chitin oligosaccharide biosynthesis in E. coli 
(60) by functional expression of the nod gene 
cluster from Rhizobium. NodC is a chitin oligomer 
synthase (Fig. 2) producing fully acetylated chitin 
oligomers of 2-5 saccharide residues (61), where 
the C-terminal domain of transmembrane NodC 
controls chain length (62). In vitro exposure of 
chitin oligosaccharides to enzymes NodB from 
Rhizobium sp. GRH2 and COD from Vibrio 
cholerae allowed for specific patterning of 
deacetylated chitosan oligomers (63). In 1997, 
Samain et al. demonstrated the production of gram 
amounts of a perfectly defined, mono-deacetylated 
chito-pentose with a GlcN unit at the nonreducing 
end in E. coli (Table 1) (64).  Novel chitosan 
oligomers have been obtained, such as N-acetyl-
lactosamine (65) and thio-chito-oligosaccharide 
analogs, where the oxygen glycosidic linkage is 
replaced with sulfur for improved stability against 
hydrolysis by chitinases (66).   
Hyaluronan 
Hyaluronic acid (HA), also known as 
hyaluronan, is known for its structural role in the 
extracellular matrix of vertebrate epithelial, neural, 
and connective tissues like cartilage. HA is a linear 
copolymer of disaccharide units of β(1→3)-
GlcNAc and β(1→4)-glucuronic acid (Fig. 1e), 
produced in varying molecular weights, by 
vertebrates and prokaryotes. The repeating 
carboxylate groups from glucuronic acid moieties 
are highly hydrophilic and HA polymers have been 
incorporated for water retention and viscosity 
properties in cosmetics for more than 100 years. 
Purified high molecular weight preparations of HA 
elicit no detectable inflammatory response in 
mammalian cells, making HA a key functional 
material in designs for surgical biomaterials and 
cell-scaffolds (67) such as HA-based hydrogels 
enabling the successful culture of rod 
photoreceptors in vitro (68). The global demand for 
HA was estimated to be worth USD 7.2 billion in 
2016; thanks to the steady increase in demand, the 
global market size is projected to reach USD 15.4 
billion by 2025 (69).  
Traditionally, HA is purified from animal 
tissues such as rooster combs and umbilical cords. 
A lower cost bacterial fermentation method has 
been developed by leveraging the natural producer 
Streptococcus zooepidemicus. However, natural 
microbial HA pathways have typically evolved as a 
masking technique to hide invading cells within the 
human body, and S. zooepidemicus is itself a 
recognized human pathogen. Endotoxins and viral 
contaminants from animal and pathogen sources are 
a source of concern and have driven development 
of sustainable Generally Recognized as Safe 
(GRAS) alternatives. Synthesis of HA has been 
demonstrated in B. subtilis (70), Lactococcus lactis  
(71), and Pichia pastoris (72). In bacteria, HA is 
synthesized from UDP-glucuronic acid (UDP-
GlcUA) and UDP-GlcNAc by a single enzyme 
complex hyaluronan synthase (HAS) (Fig. 2). 
UDP-GlcUA and UDP-GlcNAc occur naturally as 
part of cell wall synthesis which directly competes 
with HA synthesis. The relative abundance of 
precursors and HAS has a definitive effect on chain 
length and average molecular weight of resulting 
HA polymers (73).  
A key challenge for HA and most 
polysaccharide syntheses stems from the tradeoff 
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between a high ATP and NAD+ requirements 
leading to high dissolved oxygen (DO) 
requirements for electron cycling, versus low 
molecular diffusion in high viscosity cultures as the 
concentration of high molecular weight polymer 
increases. DO has a critical effect on molecular 
weight, possibly through affecting the abundance of 
precursors (74). The desired outcome of high titer 
leads to poor mixing and an increasingly anaerobic 
environment. Countering this effect mechanically 
with increased aeration and mixing is energy 
intensive and impractical at higher viscosities. In 
strains capable of anaerobic fermentation this leads 
to elevated levels of fermentation products such as 
lactic acid which limits HA production (S. 
zooepidemicus) (75). In strains that are sensitive to 
low DO such as B. subtilis, the anaerobic 
environment leads to early cessation of production 
at 3 g/L (76). This limitation in B. subtilis was 
overcome by controlled expression of 
hyaluronidase to reduce molecular weight and 
viscosity of the culture with the tradeoff that 
smaller chains are produced (6x103 Da versus 6x106 
Da) (76).  In anaerobic tolerant Corynebacterium 
glutamicum, heterologous expression of the HA 
pathway with knockout of LDH allowed for 
accumulation of 21 g/L HA with a mid-range MW 
of 2x105 - 8x105 Da (77) (Table 1). In S. 
zooepidemicus, a recombinant suicide plasmid 
added to prevent natural expression of 
hyaluronidase, yielded 9 g/L of a higher molecular 
weight product (78).  
Summary and future outlook 
Metabolic engineering and synthetic biology 
strategies have advanced the techniques for 
microbial production of biopolymers and promise 
sustainable and reliable alternatives to current 
production from natural sources. Synthetic biology 
strategies highlighted include the implementation 
of a riboswitch to balance glycolytic flux in the 
biosynthesis of chitin and HA precursor GlcNAc 
(47), expression balancing with promoter 
replacement of synthase and acetyltransferase 
genes in the biosynthesis of GlcNAc (45), 
redirection of carbon flux by deleting glycolytic 
genes in the biosynthesis of alginate (37), and 
preventing expression of degradative enzymes like 
hyaluronidase for HA biosynthesis (78).  
While efforts have successfully demonstrated 
microbial biopolymer production, there are still 
challenges to address: firstly, understanding 
competition for endogenous cellular resources, 
such as precursor sugar nucleotide pools and energy 
requirements (e.g. ATP, NAD+); secondly, 
transcriptional regulation, where synthesis is tightly 
regulated and controlled by complex regulatory 
machinery, which functions when cells need to 
construct structural components like EPS that relate 
to pathogenicity and defense mechanisms; thirdly, 
in vivo biopolymerization, where there is a need for 
better characterization of polymerization enzymes 
(79) and the steps in EPS biosynthesis even though 
gene clusters have been known for several years 
(80); and finally, extracellular secretion, which 
poses process engineering challenges where titer is 
limited by viscosity leading to mass transfer issues 
(81). Host compatibility should also be considered, 
for example, the robustness of model organisms 
like E. coli to industrial conditions. 
To address these challenges, the advent of new 
technologies and approaches is critical. While 
dynamic regulation of carbon fluxes has been 
implemented in monomeric carbohydrate 
biosynthesis like glucaric acid (82), application of 
similar strategies for biopolymer synthesis is yet to 
be explored. Precursor supply by regenerating 
sugar nucleotides can balance cellular resources 
(42), and genome-level metabolic modeling of 
microbial cell factories is instrumental to optimize 
the performance of heterologous biopolymer-
producing pathways (83). For example, model 
guided metabolic engineering followed by 
experimental validation of growth-coupled glycan 
overproducing strains identified metabolic 
imbalances that rerouted flux toward glycan 
precursor synthesis (83). 13C-metabolic flux 
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analysis is another powerful tool for identifying 
pathway bottlenecks (84) in the optimization of 
microbial biopolymer synthesis (84). DNA 
sequencing (85) and synthesis technologies coupled 
to machine learning (86), along with the 
development of CRISPR-Cas9 gene editing 
technologies, have allowed for increased 
engineering efficiency (87). Bioprospecting for 
new sequences and functions (88) can help 
characterize polymerization protein complexes and 
also help identify novel molecular targets for the 
potential of tailor-made mixed biopolymers of 
varying material properties made from 
functionalized block copolymers.   
Copolymer formulations provide further 
opportunities for tailoring, where strategies of 
metabolic engineering and growth medium 
modifications can help control biopolymer 
compositions (89). Yadav et al. demonstrated 
bacterial production of a hybrid cellulose-chitin 
copolymer for biomedical applications where 
lysozyme susceptibility allowed for in vivo 
biodegradation (90, 91). Structurally, the presence 
of GlcNAc in bacterial cellulose disrupts the highly 
ordered cellulose crystalline structure, thus 
transforming the cellulose type Iα structure to 
cellulose-chitin type II due to alterations in fibril-
fibril interactions (92). Further functionalization of 
modified bacterial cellulose through deacetylation 
can generate materials with a reactive amine 
surface that allows for various applications, such as 
engineering novel biocomposites, tissue 
engineering scaffolding, biosensor small molecule 
detection, and drug delivery vehicles (90). 
For microbial production of biopolymers to be 
considered a green technology, important criteria, 
including energy efficiency, material efficiency, 
land use, and costs metrics need to be assessed. 
While building block chemicals such as lactic acid 
and isoprene have been assessed by green metrics 
(93), an opportunity exists for assessing other 
valuable biosynthesized materials. Microbially-
produced lactic acid and the polymer polylactic 
acid have higher economic efficiency over 
chemically-produced similar materials due to 
increased energy efficiency and fermentation 
driven stereoselection of D(-) or L(+) lactic acid 
(94). Moving beyond cellular control, more 
opportunities for green processing exist, including 
valorization with CO2 and utilization of feedstocks 
from biodegradation of waste products such as 
bioplastics (95). Other metrics such as life cycle 
assessment, the E-factor, and principles of green 
chemistry should be implemented to drive a circular 
and sustainable economy forward with reduced 
waste and conservation of resources. The 
environmental and health risk of biopolymers, for 
instance, fluorine-containing bioplastics (15), need 
to be addressed.  Biopolymer microbial synthesis 
could also be suitable in sustainable systems such 
as space stations or intergalactic habitats because of 
its renewability and replicability. There is an 
overlap between closed systems designed for space 
habitation and ‘green’ technology on Earth (96).  
Emerging technologies for in silico design and 
predictions of material properties will help advance 
the cell factory approach to biopolymer production 
such as in the creation of biomimetic scaffolds 
composed of 3D cell culture polysaccharide 
hydrogels (97). Opportunities also exist for 
combination of the cell factory approach with 
manufacturing such as in the controlled-biofilm 
layering by EPS secreting microbes biofabricated 
by 3D printing, along with advances in 4D printed 
biomaterials with integrated “smart” diagnostics 
(98). Imagine a world where microbes are full cell 
factories, not just making single molecules but 
assembling entire functional materials.  
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Figure 1. Chemical structures of biopolymers highlighted in this Minireview.  
A, cellulose. B, alginate. C, chitin. D, chitosan, E, hyaluronan. Number of units is indicated on the 
bottom right of each bracket. X and Y designate different monomeric units.  
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Table 1. Overview of microbial production of carbohydrate biopolymers: Cellulose, alginate, chitin, 
chitosan, and hyaluronan. 
 
 Primary 
chemical 
structure 
Metabolic 
precursor 
Polymerizing 
enzyme 
Natural/ 
Industrial 
source 
Select examples: 
host(s), titer, scale 
Industrial 
application 
Cellulose 
 
β-(1,4)-linked 
homopolymer 
of D-Glc 
UDP–Glc Cellulose 
synthase (BcsA) 
Green plants;  
Some algae; 
Oomycetes 
Acetobacter xylinum 
BRC5, 15.3 g/L, 10-
L batch (26) 
Electronics 
(diaphragms 
of acoustic 
transducers); 
Food (nata de coco);  
Medicine (scaffolds 
for tissue engineering, 
wound dressing, soft 
tissue replacement) 
Alginate 
 
β-(1,4)-linked 
non-repeating 
heteropolymer 
of ManA and 
GulA 
GDP-ManA Glycosyltransferase 
(Alg8) 
Seaweed;  
Some 
bacteria 
Azotobacter 
vinelandii, 6.6 g/L, 
1.5-L batch reactors 
(99) 
Feed;  
Food (gelling agents, 
stabilizers);  
Medicine (tissue 
scaffolds, drug 
delivery;  
Research 
Chitin β-(1,4)-
homopolymer 
of GlcNAc 
UDP-GlcNAc Chitin synthase 
(NodC) 
Fungi; 
Crustaceans; 
Insects;  
Beaks of 
Cephalopods
; Some fish 
and 
amphibians 
GlcN: E. coli, 17 
g/L, 1-L fed batch 
(43); 
GlcNAc: E. coli, 110 
g/L, 1-L 2-phase fed 
batch (43); 
Mixture of chitin 
oligosaccharides 
penta-N-acetyl-
chitopentaose and 
tetra-N-acetyl-
chitopentaose: E. 
coli, 2.5 g/L, 2-L fed 
batch (64) 
Agriculture 
(pesticides); 
Manufacturing 
(bioprinting); 
Medicine (wound 
healing, drug 
delivery) 
 
Chitosan β-(1,4)-linked 
heteropolymer 
of GlcNAc and 
GlcN 
Hyaluronan β-(1,4)-linked 
repeating 
heteropolymer 
of disaccharide 
units of GlcUA 
and GlcNAc 
UDP-GlcUA 
+ UDP-GlcNAc 
Hyaluronan 
synthase (HasA) 
Vertebrates 
(e.g. rooster 
combs),  
Some 
bacteria 
C. glutamicum, 21.6 
g/L, 5-L fed batch 
(77) 
Cosmetics; 
Medicine 
(viscosupplementatio
n, tissue repair, drug 
delivery) 
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Figure 2. Overview of biosynthetic routes to biopolymers.  
The main steps in the microbial biosynthetic routes for cellulose, alginate, chitin, chitosan, and 
hyaluronan from glucose are briefly depicted. The solid arrow represents an enzymatic step while the 
broken arrow represents a multi-step pathway that includes a number of enzymatic steps. The yellow circle 
represents the starting material, glucose; gray circles represent intermediate metabolites; red circles 
represent a sugar nucleotide; and blue, orange, purple, and green circles represent product biopolymer 
molecules. Abbreviations: AcCoA, Acetyl Coenzyme-A; BC, F6P, fructose-6-phosphate; G1P, Glucose-1-
phosphate; G6P, glucose-6-phosphate; GDP-Man, GDP-mannose; GDP-ManA, GDP-mannuronic acid; 
GlcN-6-P, glucosamine-6-phosphate; GlcNAc-1-P, N-acetylglucosamine-1-phosphate; GlcNAc-6-P, N-
acetylglucosamine-6-phosphate; HAS, hyaluronan synthase; M1P, mannose-1-phosphate; M6P, mannose-
6-phosphate; OAA, oxaloacetate; TCA, tricarboxylic acid; UDP-Glc, UDP-glucose; UDP-GlcNAc, UDP-
N-acetylglucosamine; UDP-GlcUA, UDP-glucuronic acid; UDP-GulA, UDP-guluronic acid. 
 by guest on June 18, 2018
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
 
 
 
Synthetic biology for green biopolymers 
 
19 
 
Acknowledgements 
We thank John W. K. Oliver, Kristina Haslinger (MIT ChemE Communication Lab Fellow), and Nicolas 
R. Ball-Jones for helpful discussion regarding the manuscript. 
 by guest on June 18, 2018
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
Lisa A Anderson, M. Ahsanul Islam and Kristala L. J. Prather
Synthetic biology strategies for improving microbial synthesis of ''green'' biopolymers
 published online January 16, 2018J. Biol. Chem. 
  
 10.1074/jbc.TM117.000368Access the most updated version of this article at doi: 
 Alerts: 
  
 When a correction for this article is posted•  
 When this article is cited•  
 to choose from all of JBC's e-mail alertsClick here
 by guest on June 18, 2018
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
